MedTrace Logo

Prospective Observational Study of Antitumor Activity Correlation Between Hormonal Therapy and Expression miRNA100

NCT02950207 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2016-11-03

No results posted yet for this study

Summary

Mono-centric, observational, prospective study, designed for pts with diagnosis of hormone-positive breast cancer to evaluate the correlation between the response to hormonal treatment indicated by the reduction of the level of Ki67 and miRNA100 in two groups of patients

Conditions

Interventions

GENETIC

miRNA

miRNA extraction

Sponsors & Collaborators

  • Fondazione del Piemonte per l'Oncologia

    lead OTHER

Principal Investigators

  • Filippo Montemurro, MD · FPO-IRCCS

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2019-01-31
Completion
2019-01-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02950207 on ClinicalTrials.gov